American Portfolios Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

American Portfolios Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$17.6K	Sell	351 -327	-48%	-$18.5K	﹤0.01%	2251
2022 Q2	$33.1K	Hold	678	–	–	﹤0.01%	1990
2022 Q1	$40.7K	Hold	678	–	–	﹤0.01%	1985
2021 Q4	$53.8K	Hold	678	–	–	﹤0.01%	1832
2021 Q3	$60K	Hold	678	–	–	﹤0.01%	1680
2021 Q2	$67.5K	Hold	678	–	–	﹤0.01%	1584
2021 Q1	$60.9K	Hold	678	–	–	﹤0.01%	1530
2020 Q4	$64K	Hold	678	–	–	﹤0.01%	1335
2020 Q3	$48.7K	Buy	678 +522	+335%	+$37.4K	﹤0.01%	1326
2020 Q2	$11K	Hold	156	–	–	﹤0.01%	1886
2020 Q1	$7.79K	Hold	156	–	–	﹤0.01%	1906
2019 Q4	$9.76K	Buy	+156	New	+$8.93K	﹤0.01%	2007

Other funds holding GNOM

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

American Portfolios Advisors's GNOM Position: Q3 2022 in Review

American Portfolios Advisors reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 48% in Q3 2022, selling an estimated $18.5K and leaving 351 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2251.

American Portfolios Advisors first reported a position in GNOM in Q4 2019 and has held it in 12 quarters since. The position peaked at $67.5K in Q2 2021. 59 funds tracked by Wall St. Rank hold GNOM as of Q3 2022.

American Portfolios Advisors held 351 shares of Global X Genomics & Biotechnology ETF worth $17.6K as of Q3 2022.
American Portfolios Advisors sold 327 Global X Genomics & Biotechnology ETF shares in Q3 2022, an estimated $18.5K.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2251 holding.
American Portfolios Advisors first reported a position in Global X Genomics & Biotechnology ETF in Q4 2019 and has held it in 12 quarters since.
American Portfolios Advisors's Global X Genomics & Biotechnology ETF position peaked at $67.5K in Q2 2021.
59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.